Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 5 , Pages 651-665 , October 2009

Non-adenomatous pituitary tumours

  • Niki Karavitaki, MBBS, MSc, PhD (Locum Consultant)
    • ,
  • John A.H. Wass, MD, FRCP (Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 1865857310; Fax: +44 1865857311.

References 

  1. Bunin GR, Surawicz TS, Witman PA, et al. The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery. 1998;89:547–551
  2. Parisi JE, Mena H. Nonglial tumours. In:  Nelson JS,  Parisi JE,  Schochet SS editor. Principles and practice of neuropathology. 1st edn.. St. Louis: Mosby; 1993;p. 203–266
  3. Matson DD, Crigler JF. Management of craniopharyngioma in childhood. Journal of Neurosurgery. 1969;30:377–390
  4. Schoenberg BC, Schoenberg DG, Christine BW, et al. The epidemiology of primary intracranial neoplasms of childhood. A population study. Mayo Clinic Proceedings. 1976;51:51–56
  5. Kuratsu J, Ushio Y. Epidemiological study of primary intracranial tumours in childhood. A population-based survey in Kumamoto Prefecture, Japan. Pediatric Neurosurgery. 1996;25:240–246
  6. DeVile CJ. Craniopharyngioma. In:  Wass JAH,  Shalet SM editor. Oxford textbook of endocrinology and diabetes. 1st edn.. Oxford: Oxford University Press; 2002;p. 218–225
  7. Bailey W, Freidenberg GR, James HE, et al. Prenatal diagnosis of a craniopharyngioma using ultrasonography and magnetic resonance imaging. Prenatal Diagnosis. 1990;10:623–629
  8. Muller-Scholden J, Lehrbecker T, Muller HL, et al. Radical surgery in a neonate with craniopharyngioma-report of a case. Pediatric Neurosurgery. 2000;33:265–269
  9. Sorva R, Heiskanen O. Craniopharyngioma in Finland. A study of 123 cases. Acta Neurochirurgica. 1986;81:85–89
  10. Karavitaki N, Cudlip S, Adams CBT, et al. Craniopharyngiomas. Endocrine Reviews. 2006;27:371–397
  11. Buslei R, Nolde M, Hofman B, et al. Common mutations of beta-catenin in adamantinomatous but not in other tumours originating from the sellar region. Acta Neuropathologica. 2005;109:589–597
  12. Kato K, Nakataki Y, Kanno H, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. The Journal of Pathology. 2004;203:814–821
  13. Nelson GA, Bastian FO, Schlitt M, et al. Malignant transformation of craniopharyngioma. Neurosurgery. 1988;22:427–429
  14. Kristopaitis T, Thomas C, Petruzzelli GJ, et al. Malignant craniopharyngioma. Archives of Pathology & Laboratory Medicine. 2000;124:1356–1360
  15. Crotty TB, Scheithauer BW, Young WF, et al. Papillary craniopharyngioma: a clinico-pathological study of 48 cases. Journal of Neurosurgery. 1995;83:206–214
  16. Gorlin RJ, Chaudhry AP. The ameloblastoma and the craniopharyngioma; the similarities and differences. Oral Surgery, Oral Medicine, and Oral Pathology. 1959;12:199–205
  17. Bernstein ML, Buchino JJ. The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal. Oral Surgery, Oral Medicine, and Oral Pathology. 1983;56:502–511
  18. Weiner HL, Wisoff JH, Rosenberg ME, et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery. 1994;35:1001–1011
  19. Adamson TE, Wiestler OD, Kleihues P, et al. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. Journal of Neurosurgery. 1990;73:12–17
  20. Karavitaki N, Brufani C, Warner JT, et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clinical Endocrinology. 2005;62:397–409
  21. Byrne JV. Imaging of the pituitary. In:  Wass JAH,  Shalet SM editor. Oxford textbook of endocrinology and diabetes. 1st edn.. Oxford: Oxford University Press; 2002;p. 136–145
  22. Sartoretti-Schefer S, Wichmann W, Aguzzi A, et al. MRI differentiation of adamantinous and squamous-papillary craniopharyngiomas. AJNR. American Journal of Neuroradiology. 1997;18:77–87
  23. Fahlbush R, Honegger J, Paulus W, et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. Journal of Neurosurgery. 1999;90:237–250
  24. Paja M, Lucas T, Garcia-Uria F, et al. Hypothalamic-pituitary dysfunction in patients with craniopharyngioma. Clinical Endocrinology. 1995;42:467–473
  25. Duff JM, Meyer FB, Ilstrup DM, et al. Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery. 2000;46:291–305
  26. Van Effenterre R, Boch AL. Craniopharyngioma in adults and children. Journal of Neurosurgery. 2002;97:3–11
  27. Hoffman HJ, DeSilva M, Humphreys RP, et al. Aggressive surgical management of craniopharyngiomas in children. Journal of Neurosurgery. 1992;76:47–52
  28. Graham P, Rao Gattamaneni H, Birch J. Pediatric craniopharyngiomas: regional review. British Journal of Neurosurgery. 1992;6:187–194
  29. Love JG, Marshall TM. Craniopharyngiomas (pituitary adamantinomas). Surgery, Gynecology & Obstetrics. 1950;90:591–601
  30. Shapiro K, Till K, Grant DN. Craniopharyngiomas in childhood. A rational approach to treatment. Journal of Neurosurgery. 1979;50:617–623
  31. De Vile CJ, Grant DB, Kendall BE, et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?. Journal of Neurosurgery. 1996;85:73–81
  32. Maira G, Anile C, Rossi GF, et al. Surgical treatment of craniopharyngiomas: an evaluation of the transsphenoidal and pterional approaches. Neurosurgery. 1995;36:715–724
  33. Minniti G, Saran F, Traish D, et al. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiotherapy and Oncology. 2007;82:90–95
  34. Tomita T, Bowman RM. Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital. Child's Nervous System. 2005;21:729–746
  35. Rajan B, Ashley S, Gorman C, et al. Craniopharyngioma - long-term results following limited surgery and radiotherapy. Radiation Oncology. 1993;26:1–10
  36. Kim SK, Wang KC, Shin SH, et al. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factor. Child's Nervous System. 2001;17:531–536
  37. Elliott RE, Wisoff JH. Successful surgical treatment of craniopharyngioma in very young children. Journal of Neurosurgey: Pediatrics. 2009;3:397–406
  38. Stripp DC, Maity A, Janss AJ, et al. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. International Journal of Radiation Oncology, Biology, Physics. 2004;28:714–720
  39. Regine WF, Kramer S. Pediatric craniopharyngiomas: long-term results of combined treatment with surgery and radiation. International Journal of Radiation Oncology, Biology, Physics. 1992;24:611–617
  40. Wisoff JH. Surgical management of recurrent craniopharyngiomas. Pediatric Neurosurgery. 1994;21:108–113
  41. Kalapurakal JA, Goldman S, Hsieh YC, et al. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Medical and Pediatric Oncology. 2003;40:214–218
  42. Szeifert GT, Julow J, Slowik F, et al. Pathological changes in cystic craniopharyngiomas following intracavital 90Yttrium treatment. Acta Chirurgica Scandinavica. 1990;102:14–18
  43. Julow J, Backlund EO, Lanyi F, et al. Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas. Neurosurgery. 2007;61:288–296
  44. Hasegawa T, Kondzilka D, Hadjipanayis CG, et al. Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery. 2004;54:813–822
  45. Voges J, Sturm V, Lehrke R, et al. Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal b-emitting radioactive sources. Neurosurgery. 1997;40:263–270
  46. Takahashi H, Yamaguchi F, Teramoto A. Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children. Child's Nervous System. 2005;21:701–704
  47. Hukin J, Steinbok P, Lafay-Cousin L, et al. Intracystic bleomycin therapy for craniopharyngioma in children: the Canadian experience. Cancer. 2007;109:2124–2131
  48. Frank F, Fabrizi AP, Frank G, et al. Stereotactic management of craniopharyngiomas. Stereotactic and Functional Neurosurgery. 1995;65:176–183
  49. Chung WY, Pan DHC, Shiau CY, et al. Gamma knife radiosurgery for craniopharyngiomas. Journal of Neurosurgery. 2000;93:47–56
  50. Kobayashi T, Kida Y, Mori Y, et al. Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases. Journal of Neurosurgery. 2005;103:482–488
  51. Gopalan R, Dassoulas K, Rainey J, et al. Evaluation of the role of Gamma Knife surgery in the treatment of craniopharyngiomas. Neurosurgical Focus. 2008;24:E5
  52. Mokry M. Craniopharyngiomas: a six years experience with gamma knife radiosurgery. Stereotactic and Functional Neurosurgery. 1999;72:140–149
  53. Varlotto JM, Flickinger JC, Kondziolka D, et al. External beam irradiation of craniopharyngiomas: long-term analysis of tumour control and morbidity. International Journal of Radiation Oncology, Biology, Physics. 2002;54:492–499
  54. Brada M, Thomas DGT. Craniopharyngioma revisited. International Journal of Radiation Oncology, Biology, Physics. 1993;27:471–475
  55. Habrand J, Ganry O, Couanet D, et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. International Journal of Radiation Oncology, Biology, Physics. 1999;44:255–263
  56. Abrams LS, Repka MX. Visual outcome of craniopharyngioma in children. Journal of Pediatric Ophthalmology and Strabismus. 1997;34:223–224
  57. Harris JR, Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology. 1976;120:167–171
  58. Poretti A, Grotzer MA, Ribi K, et al. Outcome of craniopharyngioma in children: long-term complications and quality of life. Developmental Medicine and Child Neurology. 2004;46:220–229
  59. Bulow B, Attewell R, Hagmar L, et al. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumour recurrence. The Journal of Clinical Endocrinology and Metabolism. 1998;83:3897–3904
  60. Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. Lancet. 2001;357:425–431
  61. De Vile CJ, Grant DB, Hayward RD, et al. Growth and endocrine sequelae of craniopharyngioma. Archives of Disease in Childhood. 1996;75:108–114
  62. Sung DI, Chang CH, Harisiadis L, et al. Treatment results of craniopharyngiomas. Cancer. 1981;47:847–852
  63. Osborn AG, Preece MT. Intracranial cysts: radiologic-pathologic correlation and imaging approach. Radiology. 2006;239:650–664
  64. Kim JE, Kim JH, Kim OL, et al. Surgical treatment of symptomatic Rathke cleft cysts: clinical features and results with special attention to recurrence. Journal of Neurosurgery. 2004;100:33–40
  65. Fager CA, Carter H. Intrasellar epithelial cysts. Journal of Neurosurgery. 1966;24:77–81
  66. Shanklin WM. The histogenesis and histology of an integumentary type of epithelium in the human hypophysis. The Anatomical Record. 1951;109:217–231
  67. Mukkherjee JJ, Islam N, Kaltsas G, et al. Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumours that may recur. The Journal of Clinical Endocrinology and Metabolism. 1997;82:2357–2362
  68. Nishioka H, Haraoka J, Izawa H, et al. Magnetic resonance imaging, clinical manifestations, and management of Rathke's cleft. Clinical Endocrinology. 2006;64:184–188
  69. Tominaga J, Higano S, Takahashi S. Characteristics of Rathke's cleft cyst in MR imaging. Magnetic Resonance in Medical Sciences. 2003;2:1–8
  70. Harrison MJ, Morgello S, Post KD. Epithelial cystic lesions of the sellar and parasellar region: a continuum of ectodermal derivatives?. Journal of Neurosurgery. 1994;80:1018–1025
  71. Billeci D, Marton E, Tripodi M, et al. Symptomatic Rathke's cleft cysts: a radiological, surgical and pathological review. Pituitary. 2005;7:131–137
  72. Steinberg GK, Koenig GH, Golden JB. Symptomatic Rathke's cleft cysts. Report of two cases. Journal of Neurosurgery. 1982;56:290–295
  73. Bonneville F, Cattin F, Marsot-Dupuch K, et al. T1 signal hyperintensity in the sellar region: spectrum of findings. RadioGraphics. 2006;26:93–113
  74. Cohan P, Fouland A, Esposito F, et al. Symptomatic Rathke's cleft cysts: a report of 24 cases. Journal of Endocrinological Investigation. 2004;27:943–948
  75. Karavitaki N, Scheithauer BW, Watt J, et al. Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke's cleft cyst with corticotroph adenoma. Pituitary. 2008;11:317–323
  76. Longstreth WT, Dennis LK, McGuire VM, et al. Epidemiology of intracranial meningiomas. Cancer. 1993;72:639–648
  77. Louis DN, Scheithauer BW, Budka H, et al. Meningiomas. Pathology and genetics of tumours of the nervous system: World Health Organization classification of tumours. Lyon: IARC Press; 2000;p. 176–184
  78. Whittle IR, Smith C, Navoo P, et al. Meningiomas. Lancet. 2004;363:1535–1543
  79. Watson M, Gutmann DH, Peterson K, et al. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. The American Journal of Pathology. 2002;161:665–672
  80. Raoa VJ, Lamesb RA, Mitra D. Imaging characteristics of common suprasellar lesions with emphasis on MRI findings. Clinical Radiology. 2008;63:939–947
  81. Nakamura M, Roser F, Michel J, et al. The natural history of incidental meningiomas. Neurosurgery. 2003;53:62–70
  82. Stafford SL, Perry A, Suman VJ, et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clinic Proceedings. 1998;73:936–942
  83. Kallio M, Sankila R, Hakulinen T, et al. Factors affecting operative and long-term mortality in 935 patients with intracranial meningioma. Neurosurgery. 1992;31:2–12
  84. Ko KW, Nam DH, Kong DS, et al. Relationship between malignant subtypes of meningioma and clinical outcome. Journal of Clinical Neuroscience. 2007;14:747–753
  85. Dufour H, Muracciole X, Métellus P, et al. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal?. Neurosurgery. 2001;48:285–294
  86. Mendenhall WM, Morris CG, Amdur RJ, et al. Radiotherapy alone or after subtotal resection for benign skull base meningiomas. Cancer. 2003;98:1473–1482
  87. Nutting IC, Brada M, Brazil L, et al. Radiotherapy in the treatment of benign meningioma of the skull base. Journal of Neurosurgery. 1999;90:823–827
  88. Selch MT, Ahn E, Laskari A, et al. Stereotactic radiotherapy for treatment of cavernous sinus meningiomas. International Journal of Radiation Oncology, Biology, Physics. 2004;59:101–111
  89. Brell M, Villa S, Teixidor P, et al. Fractionated stereotactic radiotherapy in the treatment of exclusive cavernous sinus meningioma: functional outcome, local control, and tolerance. Surgical Neurology. 2006;65:28–34
  90. Pollock BE, Stafford SL. Results of stereotactic radiosurgery for patients with imaging defined cavernous sinus meningiomas. International Journal of Radiation Oncology, Biology, Physics. 2005;62:1427–1431
  91. Lee JYK, Niranjan A, McInerney J, et al. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. Journal of Neurosurgery. 2002;97:65–72
  92. Grunberg SM, Weiss MH, Russell CA, et al. Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma. Cancer Investigation. 2006;24:727–733

PII: S1521-690X(09)00053-0

doi: 10.1016/j.beem.2009.05.007

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 5 , Pages 651-665 , October 2009

Article Tools

* Image Usage & Resolution